Risk stratification using coronary artery calcium and potential benefit of semaglutide therapy: A cost-effectiveness

Sai Rahul Ponnana1, Tong Zhang1, Santosh Kumar Sirasapalli1

  • 1Case School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.

PubMed

Insights

Coronary artery calcium (CAC) scoring helps predict major adverse cardiovascular events (MACE) risk. This study found semaglutide therapy is more cost-effective for individuals with higher CAC scores, suggesting CAC can guide treatment decisions.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacoeconomics
  • Obesity Management

Background:

  • Coronary artery calcium (CAC) scoring effectively stratifies risk for major adverse cardiovascular events (MACE).
  • Semaglutide is a highly effective anti-obesity medication, but its high cost limits accessibility.
  • Cost-effectiveness of semaglutide therapy in relation to CAC scores requires investigation.

Purpose of the Study:

  • To evaluate the cost-effectiveness of semaglutide treatment across different coronary artery calcium (CAC) scoring groups.
  • To determine the clinical benefit and economic value of semaglutide based on CAC-defined cardiovascular risk.

Main Methods:

  • Utilized data from 38,058 CLARIFY registry participants meeting SELECT criteria, stratified by CAC score (0, 1-99, 100-399, ≥400).
  • Estimated MACE risk using multivariable-adjusted Cox proportional hazard models.
  • Developed lifetime-horizon Markov models to simulate semaglutide therapy, calculating number needed to treat (NNT) and incremental cost-effectiveness ratios (ICER).

Main Results:

  • Higher CAC scores correlated with increased MACE risk, including myocardial infarction, heart failure, stroke, and all-cause mortality.
  • Semaglutide therapy showed potential MACE NNT values of 151 for CAC=0 and 34 for CAC≥400 over 3.3 years.
  • The incremental cost-effectiveness ratio (ICER) for semaglutide decreased significantly with higher CAC scores, from $625,863/QALY for CAC=0 to $168,666/QALY for CAC≥400.

Conclusions:

  • Coronary artery calcium (CAC) scoring can serve as a valuable tool for assessing the potential clinical benefits and cost-effectiveness of lifelong semaglutide therapy in obese individuals.
  • CAC scoring may aid in personalizing treatment strategies for semaglutide to optimize outcomes and resource allocation.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
451
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
269
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
373
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
693
Benefits of Self-Esteem01:25

Benefits of Self-Esteem

Self-esteem—an individual's overall evaluation of their worth—plays a complex role in psychological functioning and well-being. It is often associated with many positive traits, such as confidence, optimism, and perseverance. Individuals with high self-esteem typically experience better sleep, manage peer pressure more effectively, and report greater life satisfaction. Conversely, low self-esteem has been consistently linked with increased risks of depression, anxiety, and poor...
199